Financhill
Back

Equity Residential Vs. Keros Therapeutics Industry Stock Comparison

Buy
67

EQR
Equity Residential

Last Price:
67.91
Seasonality Move:
2.37%
Sell
25

KROS
Keros Therapeutics

Last Price:
45.30
Seasonality Move:
4.22%
Buy
67
Equity Residential (EQR) is a Buy

Is Equity Residential a Buy, Sell or Hold?

  • The current Equity Residential [EQR] share price is $68.59. The Score for EQR is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
  • EQR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
25
Keros Therapeutics (KROS) is a Sell

Is Keros Therapeutics a Buy, Sell or Hold?

  • The current Keros Therapeutics [KROS] share price is $45.65. The Score for KROS is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • KROS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EQR Stock Price Chart

What is Equity Residential's stock price today?

  • The Equity Residential share price today is $68.59
    The current trend is moderately bullish and EQR is experiencing slight selling pressure.

KROS Stock Price Chart

What is Keros Therapeutics's stock price today?

  • The Keros Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing slight selling pressure.

EQR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.85 Buy
Relative Strength Index (14 RSI): 65.43 Buy
Chaikin Money Flow: -924659 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (64.76 - 67.52) Buy
Bollinger Bands (100): (60.57 - 66.15) Buy

KROS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.91 Sell
Relative Strength Index (14 RSI): 36.74 Sell
Chaikin Money Flow: -120480 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (46.18 - 50.06) Sell
Bollinger Bands (100): (50.42 - 64.92) Sell

EQR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 67.68 Buy
20-day SMA: 66.14 Buy
50-day SMA: 65.43 Buy
200-day SMA: 61.16 Buy
8-day EMA: 67.81 Buy
20-day EMA: 66.81 Buy
50-day EMA: 65.52 Buy
200-day EMA: 63.02 Buy

KROS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 46.5 Sell
20-day SMA: 47.57 Sell
50-day SMA: 52.43 Sell
200-day SMA: 46.94 Sell
8-day EMA: 46.46 Sell
20-day EMA: 48 Sell
50-day EMA: 51.59 Sell
200-day EMA: 50.14 Sell

Equity Residential Earnings Growth & EQR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.02 per share, an increase next quarter of $0.04 per share, a decrease this year of $0.05 per share, and an increase next year of $0.19 per share.

Keros Therapeutics Earnings Growth & KROS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.03 per share, an increase this year of $0.35 per share, and a decrease next year of $0.39 per share.

Equity Residential Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Keros Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):